25th Annual Biotech in Europe Forum

The 25th Annual Biotech in Europe Forum (#Sachs_BEF) will take place on the 8th – 9th of October 2025 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week (#SALSW), which will also incorporate the 12th Annual HealthTech Investment Forum (#Sachs_HTIF).

The physical programme will consist of panels and keynotes, which will be available on-demand by the 16th of October. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, as well as networking receptions. Recordings of the presentations will be uploaded by the 14th of October. During the online week, virtual meetings will be available through the online meeting system.

Returning for its 25th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2025, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

The main programme for the 25th Annual BEF is spread throughout 2 days (8th – 9th of October) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the Rising Stars – Biotech Seed Companies Session, alongside virtual company showcases, which will be available on-demand during the virtual week. We anticipate 650+ delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks, and advisors, with part of the audience participating virtually.

The In-Person meetings will take place during the physical event on the 8th – 9th of October, while virtual meetings will be held on the 14th – 16th of October. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect over 2000 meetings to be completed during SALSW. The conference will be held in the Central European Time (CEST) zone. The programme will consist of:

Day 1 (Wednesday, 8th of October)
State of the Industry Panel
VC & Private Equity Investor Roundtable
Platform Technologies & Novel Therapeutics Panel: Innovation & Latest Trends
Royalty Management Workshop
Obesity & Related Conditions Panel: Advanced Therapeutics
Workshop by Eli Lilly and Company
Neurological Disorders Panel: Mapping New Advances in Targets & Modalities

Day 2 (Thursday, 9th of October)
Pharma Strategy & Dealmaking Panel
China Panel: The Rise in Chinese Out-Licensing & Asset Sales
Latest Trends in Oncology Partnering Panel
Advanced Oncology Investment Panel
Investing in Early-Stage Innovation Panel
Rising Stars – Biotech Seed Companies Session

• Main Networking Reception – 8th of October
  Farewell Reception – 9th of October
  In-Person Meetings – 8th – 9th of October
  Virtual Meetings via Online Meeting System – 14th – 16th of October